This test reflects assessment of thyroxine-binding globulin (TBG) and should not be ordered alone.
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum (preferred) or plasma
1 mL (adult), 0.8 mL (pediatric)
0.7 mL (adult), 0.3 mL (pediatric) (Note: This volume does not allow for repeat testing.)
Red-top tube, gel-barrier tube, or green-top (lithium heparin) tube. Do not use oxalate, EDTA, or citrate plasma.
If a red-top tube or plasma is used, transfer separated serum or plasma to a plastic transport tube.
Thyroid function test for the diagnosis of hypothyroidism or hyperthyroidism, used with thyroxine (T4) or equivalent to provide free T4 index, FTI. An indirect measure of binding protein, the T3 uptake reflects available binding sites (ie, reflects TBG). T3 uptake is not a measurement of serum T3. It should never be used alone; rather, its usual application is use with thyroxine (T4).
Alterations in binding capacity of TBG are described with major illness and with high doses of salicylates and corticosteroids; with use of heroin, methadone, phenytoin, and perphenazine. Alterations occur with malnutrition, such as in metastatic malignancy, and are found in patients with abnormal serum protein patterns (eg, nephrotic syndromes, cirrhosis). Other states in which changes in TBG occur include infancy, acromegaly, molar and ordinary pregnancy, oral contraceptives, and with exogenous hormones including androgens, anabolic steroids, and estrogens. Hereditary increase and decrease of TBG occurs.
Electrochemiluminescence Immunoassay (ECLIA)
0 to 11 m
1 to 3 y
4 to 6 y
7 to 11 y
12 to 15 y
16 to 18 y
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|001156||T3 Uptake||3050-2||001156||T3 Uptake||%||3050-2|
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf